|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0023981,
umls-concept:C0024299,
umls-concept:C0079747,
umls-concept:C0334634,
umls-concept:C0683941,
umls-concept:C0849867,
umls-concept:C0871261,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1556085,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707455,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1998-6-4
|
|
pubmed:abstractText |
To compare mantle-cell lymphomas (MCLs) and follicle-center lymphomas (FCLs) for their features of clinical presentation, response to chemotherapy, and prognosis on the basis of a prospective randomized clinical trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BuschMM,
pubmed-author:FreundMM,
pubmed-author:HanrathR DRD,
pubmed-author:HeldLL,
pubmed-author:HerrmannRR,
pubmed-author:HiddemannWW,
pubmed-author:KaiserUU,
pubmed-author:KreuserE DED,
pubmed-author:MiddekeHH,
pubmed-author:NeubauerAA,
pubmed-author:ParwareschRR,
pubmed-author:Reuss-BorstMM,
pubmed-author:SteinHH,
pubmed-author:Terhardt-KastenEE,
pubmed-author:TiemannMM,
pubmed-author:TrümperLL,
pubmed-author:UnterhaltMM,
pubmed-author:WöltjenH HHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1922-30
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9586911-Adult,
pubmed-meshheading:9586911-Aged,
pubmed-meshheading:9586911-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9586911-Cyclophosphamide,
pubmed-meshheading:9586911-Disease-Free Survival,
pubmed-meshheading:9586911-Female,
pubmed-meshheading:9586911-Humans,
pubmed-meshheading:9586911-Lymphoma, Follicular,
pubmed-meshheading:9586911-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9586911-Male,
pubmed-meshheading:9586911-Middle Aged,
pubmed-meshheading:9586911-Mitoxantrone,
pubmed-meshheading:9586911-Prednimustine,
pubmed-meshheading:9586911-Prednisone,
pubmed-meshheading:9586911-Prospective Studies,
pubmed-meshheading:9586911-Survival Rate,
pubmed-meshheading:9586911-Vincristine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.
|
|
pubmed:affiliation |
Department of Hematology and Oncology, University of Göttingen, Germany. whiddema@univ.goettingen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
